Nivolumab and its use in the second-line treatment of metastatic urothelial cancer

Daniele Raggi, Andrea Necchi, Patrizia Giannatempo
  • Future Oncology, June 2018, Future Medicine
  • DOI: 10.2217/fon-2017-0735
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: